Research Article
MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma
Figure 4
MXRA5 expression pattern in different GBM subtypes in the CGGA and TCGA datasets. (a, c) MXRA5 was significantly enriched in mesenchymal-subtype GBM. (b, d) ROC analysis showed that MXRA5 had high sensitivity and specificity for predicting mesenchymal-subtype GBM. and indicate and , respectively.
(a) |
(b) |
(c) |
(d) |